Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127low regulatory T cells

Arthritis and Rheumatism

Volumn 65, Issue 3, 2013, Pages 627-638

  Walter, Gina J ^a   Evans, Hayley G ^a   Menon, Bina ^b   Gullick, Nicola J ^c   Kirkham, Bruce W ^c   Cope, Andrew P ^b   Geissmann, Frédéric ^a   Taams, Leonie S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIBODY; CD4 ANTIGEN; CD45RO ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 7 RECEPTOR; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; INFLAMMATION; JOINT; MALE; MEMORY T LYMPHOCYTE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATIC DISEASE; SYNOVIAL FLUID;

ADULT; ANTIGENS, CD14; ANTIGENS, CD4; ANTIGENS, CD45; ARTHRITIS, RHEUMATOID; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, IGG; SYNOVIAL MEMBRANE; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874449843     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37832     Document Type: Article

References (51)

1. + regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490-500.
2. + T regulatory cell-mediated suppression. Immunity 2009; 30: 636-45.
3. + regulatory T cells. Curr Opin Immunol 2010; 22: 575-82.
4. + T cells. Curr Opin Immunol 2009; 21: 281-5.
5. + T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911.
6. H17 lineage-specific transcription factor RORγt. Proc Natl Acad Sci U S A 2009; 106: 8635-40.
7. + regulatory T cells in humans. Proc Natl Acad Sci U S A 2009; 106: 4793-8.
8. + double-positive cells in periodontitis. J Dent Res 2012; 91: 574-9.
9. + regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J Invest Dermatol 2011; 131: 1853-60.
10. pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112: 2340-52.
11. H17 cells. Clin Immunol 2009; 131: 298-307.
12. + Treg in the presence of lineage-specific polarizing factors. Proc Natl Acad Sci U S A 2010; 107: 19402-7.
13. Beriou G, Costantino CM, Ashley CW, Yang L, Kuchroo VK, Baecher-Allan C, et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009; 113: 4240-9.
14. Wilke CM, Bishop K, Fox D, Zou W,. Deciphering the role of Th17 cells in human disease. Trends Immunol 2011; 32: 603-11.
15. Evans HG, Gullick NJ, Kelly S, Pitzalis C, Lord GM, Kirkham BW, et al. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc Natl Acad Sci U S A 2009; 106: 6232-7.
16. Van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LM, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916-20.
17. + regulatory T cells in systemic sclerosis and other rheumatic diseases. Expert Rev Clin Immunol 2011; 7: 499-514.
18. Van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS,. CD4+CD25+ regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004; 50: 2775-85.
19. + T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003; 33: 215-23.
20. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004; 6: R335-46.
21. + T cells in the peripheral blood and synovial fluid of patients with rheumatoid arthritis. Scand J Immunol 2005; 62: 312-7.
22. + T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 2005; 140: 360-7.
23. - responder T cells. J Immunol 2009; 183: 8268-79.
24. Raghavan S, Cao D, Widhe M, Roth K, Herrath J, Engstrom M, et al. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment. Ann Rheum Dis 2009; 68: 1908-15.
25. McInnes IB, Schett G,. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429-42.
26. brightCD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum 2012; 64: 671-7.
27. Korn T, Bettelli E, Oukka M, Kuchroo VK,. IL-17 and Th17 cells. Annu Rev Immunol 2009; 27: 485-517.
28. + T cell precursor. J Exp Med 2008; 205: 1903-16.
29. Hovhannisyan Z, Treatman J, Littman DR, Mayer L,. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2011; 140: 957-65.
30. McClymont SA, Putnam AL, Lee MR, Esensten JH, Liu W, Hulme MA, et al. Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. J Immunol 2011; 186: 3918-26.
31. + regulatory T cells is essential for preventing experimental graft-versus-host disease. J Immunol 2012; 189: 2890-6.
32. Vercoulen Y, Guichelaar T, Meerding J, Emmelot M, Pingen M, Storm G, et al. Application of cultured human regulatory T cells requires preclinical in vivo evaluation. J Allergy Clin Immunol 2012; 129: 852-5.e3.
33. Evans HG, Suddason T, Jackson I, Taams LS, Lord GM,. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc Natl Acad Sci U S A 2007; 104: 17034-9.
34. Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK,. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 2006; 203: 2785-91.
35. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007; 204: 1849-61.
36. O'Connor RA, Taams LS, Anderton SM,. CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation. Clin Exp Immunol 2010; 159: 137-47.
37. H17 responses in a Stat3-dependent manner. Science 2009; 326: 986-91.
38. Koch MA, Tucker-Heard G, Perdue NR, Killebrew JR, Urdahl KB, Campbell DJ,. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009; 10: 595-602.
39. H2 responses. Nature 2009; 458: 351-6.
40. Van Amelsfort JM, van Roon JA, Noordegraaf M, Jacobs KM, Bijlsma JW, Lafeber FP, et al. Proinflammatory mediator-induced reversal of CD4+,CD25+ regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 2007; 56: 732-42.
41. hi T-regulatory cells. Blood 2006; 108: 253-61.
42. + T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033-6.
43. - T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J Immunol 2007; 178: 6725-9.
44. Yang XO, Nurieva R, Martinez GJ, Kang HS, Chung Y, Pappu BP, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008; 29: 44-56.
45. Samson M, Audia S, Janikashvili N, Ciudad M, Trad M, Fraszczak J, et al. Inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum 2012; 64: 2499-503.
46. Herrath J, Muller M, Amoudruz P, Janson P, Michaelsson J, Larsson PT, et al. The inflammatory milieu in the rheumatic joint reduces regulatory T-cell function. Eur J Immunol 2011; 41: 2279-90.
47. McGovern JL, Nguyen DX, Notley CA, Mauri C, Isenberg DA, Ehrenstein MR,. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy. Arthritis Rheum 2012; 64: 3129-38.
48. bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004; 172: 6435-43.
49. Haufe S, Haug M, Schepp C, Kuemmerle-Deschner J, Hansmann S, Rieber N, et al. Impaired suppression of synovial fluid CD4+CD25- T cells from patients with juvenile idiopathic arthritis by CD4+CD25+ Treg cells. Arthritis Rheum 2011; 63: 3153-62.
50. + regulatory T cells. J Immunol 2008; 181: 7350-5.
51. Wehrens EJ, Mijnheer G, Duurland CL, Klein M, Meerding J, van Loosdregt J, et al. Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells. Blood 2011; 118: 3538-48.